www.leadleo.com | --- | --- | --- | --- | --- | --- | |------------------------------|-------------------------------------------------------------------------------|-------|-------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...

Investment Rating - The report does not provide a specific investment rating for the electric vehicle battery tray industry Core Insights - The electric vehicle battery tray, also known as battery box or battery holder, is a crucial component of the power system in electric vehicles, ensuring safety and structural integrity [3][4] - The industry is experiencing rapid growth driven by the increasing demand for electric vehicles and advancements in battery integration technologies [10][11] - The market size of the electric vehicle battery tray industry has grown from 5.493 billion RMB in 2021 to 16.529 billion RMB in 2023, with a compound annual growth rate (CAGR) of 73.47% [39] - The industry is expected to continue expanding, with projections indicating a market size of 58.437 billion RMB by 2028, reflecting a CAGR of 24.67% from 2024 to 2028 [39] Industry Definition - The electric vehicle battery tray is a key component that supports the battery system, requiring high strength and precision to balance weight and safety [3][4] - The industry is categorized based on battery structure, materials used, and welding methods [6][7] Industry Characteristics - The electric vehicle battery tray industry develops in tandem with the electric vehicle sector, with significant growth in production and sales [10][11] - Aluminum alloy is the primary material used for battery trays due to its lightweight and high strength [12] - There is a trend towards lightweight and integrated designs in battery tray development [10][15] Industry Development History - The industry has evolved from using steel trays to aluminum alloy trays, reflecting a shift towards lightweight materials [16][18] - Recent advancements include the adoption of CTP (cell-to-pack) and CTC (cell-to-chassis) technologies, which enhance integration efficiency [19] Industry Chain Analysis - The upstream supply chain includes raw materials such as aluminum ingots and steel, which are critical for battery tray production [21][26] - The midstream consists of battery tray manufacturing, where leading companies are gaining competitive advantages through scale and technology [23][30] - The downstream market primarily involves battery manufacturers and vehicle manufacturers, with increasing demand for innovative battery tray solutions [31][33] Market Size and Growth - The electric vehicle battery tray market is projected to grow significantly, driven by the rapid expansion of the electric vehicle market in China, which accounted for over 60% of global sales in 2023 [40] - The cumulative production of power batteries reached 616.3 GWh in 2023, indicating robust growth in the battery sector that supports the battery tray market [31][40]

Investment Rating - The report does not explicitly state an investment rating for the liquid cooling ultra-fast charging industry Core Insights - Liquid cooling ultra-fast charging technology utilizes liquid cooling to achieve rapid charging for electric vehicles, facing challenges such as high costs and lack of standardization. However, with technological advancements and increasing market demand, its application prospects are broad. The market size is rapidly growing, driven by the increase in production and sales of new energy vehicles and consumer preference for fast charging. Future growth will be further propelled by the rise of high-power charging models and the increasing cooling demands of data centers [4][5][24]. Industry Definition - Liquid cooling ultra-fast charging refers to the rapid charging technology for electric vehicles that employs liquid cooling. As the electric vehicle market rapidly develops, charging infrastructure is continuously improving to meet user demands for faster and more efficient charging. The technology effectively dissipates heat during high-power operation, ensuring efficiency and stability [5][6]. Industry Characteristics - The liquid cooling ultra-fast charging industry is characterized by high investment thresholds, strong dependence on the new energy vehicle sector, and a lack of unified industry standards. The initial investment is relatively high due to the complexity of technology and equipment, requiring significant funding for research and development, as well as specialized manufacturing processes [8][9][10]. Development History - The liquid cooling ultra-fast charging industry has reached two stages: the budding phase (2019-2022) and the initiation phase (2023-present). During the budding phase, various companies launched and deployed multiple liquid cooling technologies globally. The initiation phase has seen leading companies like CATL and Huawei release and deploy efficient liquid cooling technologies, accelerating the development of a comprehensive liquid cooling ultra-fast charging network [11][12][13]. Industry Scale - From 2018 to 2023, the market size of the liquid cooling ultra-fast charging industry grew from 927 million RMB to 38.82 billion RMB, with a compound annual growth rate (CAGR) of 111.07%. It is projected that from 2024 to 2028, the market size will increase from 57.88 billion RMB to 295.86 billion RMB, with a CAGR of 50.36% [24][25]. Policy Overview - Recent policies advocate for the acceleration of charging infrastructure development, including the expansion of charging networks in urban centers and along highways. These policies aim to enhance the service capabilities of charging facilities and promote the integration of smart management systems to meet the growing demand for electric vehicle charging [29][30][31]. Competitive Landscape - The liquid cooling ultra-fast charging industry exhibits high market concentration, with leading companies such as Huawei in the first tier, followed by NIO and other firms in the second tier. The high costs associated with liquid cooling technology limit the number of participants, leading to a market tilt towards a few large enterprises. Future market concentration is expected to increase as mid-tier companies develop new ultra-fast charging products and expand their charging station networks [34][35][36].

Industry Overview - The health food market for improving sleep demonstrates resilience amidst global economic fluctuations, reflecting increased consumer health awareness and demand for quality sleep [3] - Insomnia is a common sleep disorder, with consumers increasingly opting for non-pharmaceutical treatments, leading to heightened interest in sleep-improving health foods [4] - Traditional Chinese medicine, particularly ingredients like sour jujube seed, plays a significant role in the formulation of sleep-improving health foods in China [5] Market Size and Growth - The market size of sleep-improving health foods in China grew from 14.21 billion yuan in 2019 to 16.22 billion yuan in 2023, with a CAGR of 3.4% [27] - The market is projected to grow from 16.56 billion yuan in 2024 to 21.24 billion yuan in 2028, with a CAGR of 6.4% [27] - Sales volume is expected to increase from 137 million units in 2023 to 163 million units by 2028 [27] Industry Chain Analysis - The upstream sector of the sleep-improving health food industry primarily consists of raw material suppliers, including traditional Chinese medicine ingredients like sour jujube seed [32] - The midstream sector involves health food manufacturers, with over 700 registered sleep-improving health food products as of June 2024, predominantly in capsule form [32] - The downstream sector includes sales channels such as pharmacies and supermarkets, with increasing demand for products that effectively improve sleep quality [32] Competitive Landscape - The industry is divided into three tiers: Tier 1 includes companies like By-Health and Lily Health, which focus on nutritional health foods and have strong R&D capabilities [42] - Tier 2 includes companies such as Sirio Pharma and Tong Ren Tang, leveraging their pharmaceutical backgrounds and brand influence [43] - Tier 3 consists of subsidiaries of pharmaceutical groups with niche market positioning and growing R&D potential [43] Key Ingredients and Trends - Active peptides and amino acids are key ingredients in sleep-improving health foods, with components like tryptophan and GABA playing significant roles in sleep regulation [19] - The industry is moving towards higher levels of specialization and standardization, driven by consumer demand for natural and safe sleep aids [22] - The integration of traditional Chinese medicine with modern health food formulations continues to be a dominant trend in the industry [5]

Investment Rating - The report does not explicitly state an investment rating for the liquid cooling energy storage temperature control industry Core Insights - The liquid cooling energy storage temperature control market is projected to grow significantly, with a market size of 31.95 billion RMB in 2023, expected to reach 43.34 billion RMB in 2024, and 86.37 billion RMB by 2028, indicating a compound annual growth rate (CAGR) of 35.64% from 2023 to 2024 and 5.19% from 2027 to 2028 [19][21] - The penetration rate of liquid cooling in energy storage temperature control is expected to rise from 85% in 2023 to 98% by 2028, reflecting a strong adoption trend in the industry [31][32] - The average energy storage duration is projected to increase slightly from 2.1 hours in 2022 to 2.4 hours by 2028, indicating improvements in energy storage efficiency [27][29] Market Size Overview - The liquid cooling energy storage market size in billion RMB from 2019 to 2028 is as follows: - 2019: 0.14 - 2020: 0.53 - 2021: 1.39 - 2022: 6.05 - 2023: 31.95 - 2024E: 43.34 - 2025E: 48.71 - 2026E: 73.89 - 2027E: 82.1 - 2028E: 86.37 The growth rates for these years show significant increases, particularly from 2022 to 2023 at 428.11% [19][21] Lithium Battery Installation Scale - The lithium battery installation scale in GWh from 2019 to 2028 is as follows: - 2019: 3.06 - 2020: 5.89 - 2021: 10.26 - 2022: 33.61 - 2023: 46.99 - 2024E: 57.02 - 2025E: 63.43 - 2026E: 95.22 - 2027E: 94.05 - 2028E: 97.92 The growth rates indicate a peak growth of 227.59% from 2021 to 2022 [19][29] Energy Storage Market Share - The lithium battery energy storage market share from 2019 to 2028 is as follows: - 2019: 80.6% - 2020: 92% - 2021: 90% - 2022: 97% - 2023: 99% - 2024E: 96% - 2025E: 93% - 2026E: 90% - 2027E: 87% - 2028E: 85% The market share shows a gradual decline after 2023, indicating a potential shift in market dynamics [23][25] Average Energy Storage Duration - The average energy storage duration in hours from 2019 to 2028 is as follows: - 2019: 2 - 2020: 2 - 2021: 2 - 2022: 2.1 - 2023: 2.1 - 2024E: 2.2 - 2025E: 2.2 - 2026E: 2.3 - 2027E: 2.3 - 2028E: 2.4 The growth rates indicate slight improvements in energy storage duration over the years [27][29]

Investment Rating - The report does not explicitly state an investment rating for the flexible OLED panel industry Core Insights - The flexible OLED panel market is experiencing significant growth, with Chinese manufacturers expected to capture over 50% market share in small-sized OLED panels for the first time, surpassing South Korean competitors [3][20][28] - The report highlights the importance of key materials such as CPI and UTG in the production of foldable screens, which are crucial for performance and cost [3][4] - Innovations in technology, such as LTPO and ultra-thin glass, are enabling Chinese smartphone brands to design new foldable models, increasing demand for domestic OLED panels [3][26] Summary by Sections Upstream Materials - The upstream segment includes the supply of flexible substrates, organic materials, and inorganic semiconductor materials, with a high technical barrier for key materials like CPI and UTG [4][5] - The domestic production rate for these materials remains low, indicating potential for growth in local manufacturing capabilities [5] Midstream Production - Major players in the flexible OLED panel production include Samsung Display, LGD, and Chinese manufacturers like BOE and Tianma, with Samsung maintaining a dominant position [13][15] - The report notes that flexible OLED panels have a gross margin of around 50%, significantly higher than rigid OLED panels, which have a margin of about 30% [9][10] - Chinese manufacturers are ramping up production capacity, with BOE and others expected to increase their output significantly by 2027 [17][18] Downstream Demand - The global shipment of flexible OLED panels is projected to grow rapidly, with shipments expected to reach 430 million equivalent flat smartphone panels in 2023, up from 140 million in 2019, reflecting a compound annual growth rate of 32% [28][29] - The demand for flexible OLED panels is driven by the increasing penetration of these panels in smartphones, particularly in mid to high-end models [29] - The report anticipates that the introduction of OLED panels in Apple's iPad Pro in 2024 will further accelerate market penetration in the mid-size segment [29]

Investment Rating - The report does not provide a specific investment rating for the internet healthcare industry [4]. Core Insights - The internet healthcare industry in China has evolved from basic medical information queries to a comprehensive service system that integrates traditional healthcare with digital technologies [5][27]. - The market size of the internet healthcare industry has grown from 26.079 billion RMB in 2019 to 124.573 billion RMB in 2023, with a compound annual growth rate (CAGR) of 47.84%. It is projected to reach 421.976 billion RMB by 2028, with a CAGR of 27.07% [27][28]. Industry Definition - Internet healthcare refers to a new type of healthcare service that deeply integrates traditional healthcare services with information technologies such as mobile communication, cloud computing, IoT, and big data [5][9]. - The industry aims to provide more convenient and efficient medical services while optimizing resource allocation and improving service quality [5][9]. Industry Characteristics - The industry is characterized by innovation-driven growth, high regulatory barriers, and intense competition [9][11]. - Technological innovations, such as AI and big data, are central to enhancing service efficiency and patient experience [10][30]. - The regulatory environment is complex, with policies that both support and challenge industry growth [11][39]. Development History - The internet healthcare industry in China has undergone four stages: nascent (2000-2013), rapid growth (2014-2015), cooling (2016-2019), and accelerated growth (2020-present) [13][15]. - The current stage is marked by a mature service system that includes smart consultations, health management, and online medication purchasing [17][29]. Industry Chain Analysis - The upstream of the industry includes hardware facilities, cloud service providers, and pharmaceutical manufacturers [18][20]. - The midstream consists of internet healthcare platforms and health management companies, benefiting from increasing consumer internet penetration [18][22]. - The downstream focuses on end-users, with a growing number of active consumers in online pharmacies [24][25]. Market Size and Growth - The internet healthcare market size has shown significant growth, with a historical increase from 26.079 billion RMB in 2019 to 124.573 billion RMB in 2023 [27]. - The market is expected to continue expanding, driven by supportive policies and increasing consumer demand for healthcare services [28][29]. Policy Support - The Chinese government has issued multiple policies to encourage the development of internet healthcare, emphasizing the integration of new technologies [28][33]. - Policies aim to enhance healthcare service efficiency and accessibility, promoting a more robust healthcare system [28][39]. Competitive Landscape - The industry features a tiered competitive structure, with leading companies like Alibaba Health and JD Health dominating the market [39][40]. - The competition is intensifying as more companies enter the market, driven by the potential for high returns in the internet healthcare sector [39][40].

Investment Rating - The report does not provide a specific investment rating for the financial large model industry Core Insights - The financial large model, as a vertical application of generative AI in the financial sector, demonstrates high technical superiority and industry compatibility, despite facing challenges such as computing power bottlenecks and intense market competition. The market is expected to grow rapidly in the coming years, driven by technological collaboration and the potential of AI agents [4][5][13]. Industry Definition - The financial large model is defined as the vertical research and application of generative large models in the financial sector, supported by data, algorithms, and computing power. It is a highly popular industry within the AI sector and is characterized by its technical superiority and practical feasibility [5]. Industry Classification - The financial large model industry can be classified based on service areas, application practices, and open-source status. Key categories include banking models, insurance models, securities models, and trust models, each focusing on enhancing operational efficiency and risk management [6][10]. Industry Characteristics - The financial large model industry faces short-term computing power bottlenecks but is expected to see gradual growth in computing power over the long term. The market is currently in its early stages, with significant potential for growth as demand for applications in risk management and customer service increases [13][16]. Development History - The emergence of ChatGPT at the end of 2022 marked a significant turning point for the financial large model industry, leading to rapid advancements in technology and applications within the financial sector starting from March 2023 [17][19]. Industry Scale - The market size of the financial large model industry is projected to grow from 0.62 billion RMB in 2019 to 26.46 billion RMB in 2024, with a compound annual growth rate (CAGR) of 111.99%. The growth is expected to continue, reaching 310.44 billion RMB by 2029 [37][39]. Policy Overview - Recent policies aim to promote the integration of technology and finance, enhancing the development of financial large models. Initiatives include low-cost credit support for high-tech enterprises and the establishment of a comprehensive national computing network [55][56].

Investment Rating - The report does not explicitly state an investment rating for the small molecule anti-cancer targeted drug industry in China. Core Insights - The small molecule anti-cancer targeted drug market in China is projected to grow from RMB 73.4 billion in 2023 to RMB 207.5 billion by 2030, with a compound annual growth rate (CAGR) of 16.0%, significantly outpacing global growth rates [3][80]. - The report highlights the increasing demand for innovative treatment options due to the high incidence of cancer in China, particularly lung, stomach, colorectal, liver, breast, and esophageal cancers [3]. - The report emphasizes the competitive advantages of Tongyuan Kang Pharmaceutical, which has rapidly completed its IPO process and is recognized for its efficient operations and strong market potential [4]. Summary by Sections Industry Overview - The report outlines the current state of the small molecule anti-cancer targeted drug market in China, noting the significant demand driven by the high cancer incidence [3]. - It identifies the market's growth trajectory, with a forecasted market size increase to RMB 207.5 billion by 2030 [3][80]. Company Analysis: Tongyuan Kang Pharmaceutical - Tongyuan Kang has demonstrated operational efficiency by becoming the 66th biotech company listed on the Hong Kong Stock Exchange under Rule 18A, completing its IPO in less than seven months [4]. - The company possesses a leading research and development pipeline, with its core product TY-9591 being the only EGFR-TKI undergoing head-to-head clinical trials against Osimertinib [4]. - The rising cancer incidence and demand for precision medicine position targeted drugs as a preferred treatment option, providing significant market opportunities for Tongyuan Kang [4]. Industry Trends - The report notes the diversification of anti-cancer targets and the accelerated launch of products in the small molecule targeted drug sector [51]. - It highlights the increasing importance of small molecule targeted drugs in cancer treatment and the growing demand for pharmaceutical research and manufacturing outsourcing [51][44].

Investment Rating - The report provides a positive investment rating for the oncology medical services industry, indicating a strong growth potential in the coming years [27]. Core Insights - The oncology medical services market in China is projected to grow significantly, with the market size expected to reach approximately 66.73 billion RMB by 2027, up from 33.15 billion RMB in 2018, reflecting a compound annual growth rate (CAGR) of around 10.32% [28][49]. - The report highlights the increasing number of cancer patients and the rising average treatment costs as key drivers for market growth [28][41]. - Public hospitals are expected to maintain a high patient acceptance rate, although a gradual decline is anticipated, from 96% in 2018 to 90% by 2027 [34][52]. Market Size Overview - The oncology medical services market size from 2018 to 2027 is detailed as follows: - 2018: 33.15 billion RMB - 2019: 36.86 billion RMB - 2020: 40.78 billion RMB - 2021: 45.25 billion RMB - 2022: 49.77 billion RMB - 2023E: 55.16 billion RMB - 2024E: 60.28 billion RMB - 2025E: 66.55 billion RMB - 2026E: 73.44 billion RMB - 2027E: 81.02 billion RMB [28]. Treatment Market Size - The oncology treatment market size is projected as follows: - 2018: 29.94 billion RMB - 2019: 32.67 billion RMB - 2020: 35.67 billion RMB - 2021: 38.97 billion RMB - 2022: 42.5 billion RMB - 2023E: 46.78 billion RMB - 2024E: 50.98 billion RMB - 2025E: 55.8 billion RMB - 2026E: 61.03 billion RMB - 2027E: 66.73 billion RMB [28][49]. Screening Market Size - The oncology screening market size is expected to grow as follows: - 2018: 3.21 billion RMB - 2019: 4.18 billion RMB - 2020: 5.1 billion RMB - 2021: 6.29 billion RMB - 2022: 7.27 billion RMB - 2023E: 8.38 billion RMB - 2024E: 9.3 billion RMB - 2025E: 10.75 billion RMB - 2026E: 12.41 billion RMB - 2027E: 14.29 billion RMB [28]. Average Treatment Costs - The average treatment costs are projected to increase from: - 2018: 66,200 RMB - 2019: 70,100 RMB - 2020: 74,300 RMB - 2021: 78,800 RMB - 2022: 83,500 RMB - 2023E: 89,400 RMB - 2024E: 94,700 RMB - 2025E: 100,400 RMB - 2026E: 106,400 RMB - 2027E: 112,800 RMB [39][41]. Patient Numbers - The number of oncology patients is expected to rise, with public hospital patient numbers projected as follows: - 2018: 4.15 million - 2019: 4.24 million - 2020: 4.33 million - 2021: 4.42 million - 2022: 4.51 million - 2023E: 4.61 million - 2024E: 4.7 million - 2025E: 4.78 million - 2026E: 4.85 million - 2027E: 4.93 million [37][41].